After an analysis of the current GLP-1 RA research landscape, its quite clear that retatrutides biggest competition is VK2735
Possible Mechanisms Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, regulates blood sugar by slowing digestion, reducing appetite, and increasing insulin release
If GLP-1 use jumps, there will likely be fewer people with prediabetes and obesity-related type 2 diabetes
If youre prescribed a GLP-1 for Type 2 diabetes, cardiovascular risk reduction, obstructive sleep apnea, or severe fatty liver disease, your out-of-pocket costs will depend on the specific drug and your Medicare Part D coverage details, including whether your plan has that particular drug on its formulary (covered drug list)
The treatment lasted for 16 weeks